- Home
- INVE vs PTHL Comparison
INVE vs PTHL Comparison
Compare INVE & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVE
- PTHL
- Stock Information
- Founded
- INVE 1990
- PTHL 1998
- Country
- INVE United States
- PTHL China
- Employees
- INVE N/A
- PTHL N/A
- Industry
- INVE Computer peripheral equipment
- PTHL
- Sector
- INVE Technology
- PTHL
- Exchange
- INVE Nasdaq
- PTHL Nasdaq
- Market Cap
- INVE 87.1M
- PTHL 85.4M
- IPO Year
- INVE 1997
- PTHL 2024
- Fundamental
- Price
- INVE $3.70
- PTHL $0.73
- Analyst Decision
- INVE Strong Buy
- PTHL
- Analyst Count
- INVE 2
- PTHL 0
- Target Price
- INVE $5.50
- PTHL N/A
- AVG Volume (30 Days)
- INVE 48.9K
- PTHL 2.6M
- Earning Date
- INVE 08-07-2025
- PTHL 01-01-0001
- Dividend Yield
- INVE N/A
- PTHL N/A
- EPS Growth
- INVE N/A
- PTHL N/A
- EPS
- INVE 3.12
- PTHL N/A
- Revenue
- INVE $23,538,000.00
- PTHL $448,196.00
- Revenue This Year
- INVE N/A
- PTHL N/A
- Revenue Next Year
- INVE $9.98
- PTHL N/A
- P/E Ratio
- INVE $1.19
- PTHL N/A
- Revenue Growth
- INVE N/A
- PTHL N/A
- 52 Week Low
- INVE $2.86
- PTHL $0.51
- 52 Week High
- INVE $4.29
- PTHL $32.00
- Technical
- Relative Strength Index (RSI)
- INVE 55.51
- PTHL 27.50
- Support Level
- INVE $3.64
- PTHL $0.56
- Resistance Level
- INVE $3.94
- PTHL $1.00
- Average True Range (ATR)
- INVE 0.18
- PTHL 0.11
- MACD
- INVE 0.00
- PTHL 0.64
- Stochastic Oscillator
- INVE 51.02
- PTHL 45.45
About INVE Identiv Inc.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.